News
CVALF
2.760
NaN%
--
These low-priced stocks are flashing overbought signals
Seeking Alpha · 09/04 16:19
Covalon Technologies GAAP EPS of $0.10 beats by $0.09, revenue of $10M beats by $3.14M
Seeking Alpha · 08/27 11:04
Covalon Technologies reports Q2 results
Seeking Alpha · 05/21 16:15
Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
Barchart · 02/19 15:15
Covalon Technologies GAAP EPS of $0.01, revenue of $8.69M
Seeking Alpha · 12/11/2025 12:05
Covalon Technologies Ltd. declares CAD 0.15 dividend
Seeking Alpha · 10/21/2025 11:45
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
Barchart · 09/25/2025 06:00
More
Webull provides a variety of real-time CVALF stock news. You can receive the latest news about Covalon Technologies Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CVALF
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.